Molecular Partners AG
MOLN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4,970 | $7,038 | $189,556 | $9,330 |
| % Growth | -29.4% | -96.3% | 1,931.7% | – |
| Cost of Goods Sold | $47,504 | $47,844 | $50,749 | $55,718 |
| Gross Profit | -$42,534 | -$40,806 | $138,807 | -$46,388 |
| % Margin | -855.8% | -579.8% | 73.2% | -497.2% |
| R&D Expenses | $48,604 | $48,784 | $50,749 | $55,718 |
| G&A Expenses | $17,164 | $18,995 | $21,822 | $16,906 |
| SG&A Expenses | $17,164 | $18,995 | $21,822 | $16,906 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$47,085 | -$47,477 | $372 | $125 |
| Operating Expenses | $18,683 | $20,302 | $72,943 | $72,749 |
| Operating Income | -$61,217 | -$61,108 | $116,613 | -$63,418 |
| % Margin | -1,231.7% | -868.3% | 61.5% | -679.7% |
| Other Income/Exp. Net | $7,176 | -$876 | $1,240 | -$365 |
| Pre-Tax Income | -$54,041 | -$61,984 | $117,853 | -$63,783 |
| Tax Expense | $2 | $0 | $0 | $2 |
| Net Income | -$54,043 | -$61,984 | $117,853 | -$63,785 |
| % Margin | -1,087.4% | -880.7% | 62.2% | -683.7% |
| EPS | -1.59 | -1.89 | 3.63 | -2.06 |
| % Growth | 15.9% | -152.1% | 276.2% | – |
| EPS Diluted | -1.59 | -1.89 | 3.54 | -2.06 |
| Weighted Avg Shares Out | 34,033 | 32,771 | 32,470 | 31,005 |
| Weighted Avg Shares Out Dil | 34,033 | 32,771 | 33,266 | 31,005 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,384 | $4,279 | $1,196 | $108 |
| Interest Expense | $25 | $49 | $648 | $608 |
| Depreciation & Amortization | $2,369 | $2,420 | $2,387 | $2,565 |
| EBITDA | -$51,647 | -$59,515 | $119,000 | -$60,662 |
| % Margin | -1,039.2% | -845.6% | 62.8% | -650.2% |